| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer
1 company
Finck Barbara K is a Chief Medical Officer at Coherus Oncology, Inc.. Recent SEC Form 4 filings include 0 buys and 5 sells.
Estimated insider holdings value: $57K based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 10, 2018 | CHRS Coherus Oncology, Inc. | Chief Medical Officer | Sale+OE | 1,760 | $18.58 | $32,698.86 | -4.5% | |
| Aug 13, 2018 | CHRS Coherus Oncology, Inc. | Chief Medical Officer | Sale+OE | 1,760 | $19.02 | $33,479.95 | -4.5% | |
| Jul 10, 2018 | CHRS Coherus Oncology, Inc. | Chief Medical Officer | Sale+OE | 1,760 | $15.01 | $26,415.00 | -2.3% | |
| Jun 18, 2018 | CHRS Coherus Oncology, Inc. | Chief Medical Officer | Sale+OE | 1,760 | $15.00 | $26,400.00 | -4.5% |